ARDS - Nursing Case Study
Pathophysiology
• Primary mechanism: Inflammatory response leads to increased permeability of the alveolar-capillary barrier, causing non-cardiogenic pulmonary edema and impaired gas exchange.
• Secondary mechanism: Activation of immune cells and release of pro-inflammatory cytokines exacerbate alveolar damage and surfactant dysfunction, resulting in atelectasis and reduced lung compliance.
• Key complication: Severe hypoxemia due to ventilation-perfusion mismatch and shunting, necessitating mechanical ventilation and intensive respiratory support.
Patient Profile
Demographics:
56-year-old male, construction worker
History:
• Key past medical history: Hypertension, Type 2 Diabetes Mellitus, Chronic Obstructive Pulmonary Disease (COPD), Obstructive Sleep Apnea
• Current medications: Lisinopril, Metformin, Albuterol Inhaler, CPAP therapy at night
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Severe shortness of breath and persistent cough
• Key symptoms: Difficulty breathing, high fever, chest pain, confusion, fatigue
• Vital signs: Heart rate 135 bpm, Blood pressure 90/60 mmHg, Respiratory rate 32 breaths per minute, Oxygen saturation 78% on room air, Temperature 39.5°C (103.1°F)
Section 1
Change in Patient Status:
Shortly after admission to the intensive care unit, the patient's condition deteriorates rapidly. Despite high-flow oxygen therapy, his oxygen saturation continues to plummet, dropping to 72%, and he exhibits signs of increasing respiratory distress, including the use of accessory muscles and intercostal retractions. The patient's mental status declines further, with profound confusion progressing to unresponsiveness, indicating possible hypoxic encephalopathy. Auscultation reveals diffuse crackles throughout all lung fields, and arterial blood gas analysis shows a pH of 7.28, PaCO2 of 55 mmHg, and PaO2 of 48 mmHg, confirming severe respiratory acidosis and hypoxemia.
With the escalating severity of his condition, the medical team initiates mechanical ventilation. However, the patient's hypotension worsens upon initiation of positive pressure ventilation, with blood pressure dropping to 80/50 mmHg, raising concerns for potential hemodynamic instability due to decreased venous return. To address this, the team administers intravenous fluids and considers vasopressor support with norepinephrine to maintain adequate perfusion. Despite these interventions, the patient develops a new complication: pulmonary barotrauma, evidenced by subcutaneous emphysema and diminished breath sounds on the left side, suggesting a possible pneumothorax. This requires immediate attention and further intervention to stabilize the patient and prevent further deterioration.
Section 2
New Diagnostic Results:
Following the acute decompensation and suspected pneumothorax, the medical team urgently orders a chest X-ray and a CT scan to confirm the presence and extent of the pulmonary barotrauma. The imaging reveals a tension pneumothorax on the left side, with significant mediastinal shift towards the right, further compressing the already compromised lung function and exacerbating the patient's respiratory distress. Additionally, the CT scan indicates diffuse bilateral infiltrates consistent with ARDS, as well as the presence of subcutaneous air tracking along the soft tissues of the chest wall.
Concurrently, laboratory results return with alarming findings. The complete blood count shows a marked leukocytosis with a white blood cell count of 18,000/mm³, suggesting a possible infectious etiology contributing to the ARDS. Blood cultures are pending, but there's an elevated C-reactive protein at 15 mg/dL and procalcitonin levels indicative of sepsis. The metabolic panel reveals worsening renal function, with creatinine climbing to 2.4 mg/dL and blood urea nitrogen at 45 mg/dL, pointing towards acute kidney injury potentially due to hypoperfusion and sepsis.
Armed with these new diagnostic insights, the team faces critical decisions. The immediate priority is decompression of the tension pneumothorax, which requires needle decompression followed by chest tube insertion to stabilize respiratory mechanics. Simultaneously, the team must initiate broad-spectrum antibiotics to target the underlying infection, while carefully titrating vasopressors and fluids to address the hemodynamic instability without exacerbating the pulmonary edema. This complex interplay of interventions requires meticulous monitoring and adjustment, challenging the clinical team's advanced critical thinking and judgment to navigate the patient's precarious condition.
Section 3
Response to Interventions:
Following the emergency procedures, the tension pneumothorax is successfully decompressed, with immediate improvement in the patient’s oxygenation and a reduction in respiratory distress, evidenced by a decrease in the respiratory rate from 36 to 28 breaths per minute. The chest tube insertion confirms the evacuation of air and allows for gradual re-expansion of the left lung, alleviating the mediastinal shift. However, the patient remains critically ill, requiring ongoing mechanical ventilation with high positive end-expiratory pressure to maintain adequate oxygenation, given the underlying ARDS.
Despite the initial stabilization, the patient's hemodynamic status remains tenuous. Continuous monitoring reveals persistent hypotension with a mean arterial pressure hovering around 60 mmHg, necessitating the escalation of vasopressor support. Dopamine infusion is increased to 10 mcg/kg/min, but the patient continues to exhibit signs of poor peripheral perfusion, such as mottled skin and delayed capillary refill. Meanwhile, the broad-spectrum antibiotics are initiated, but the patient's fever spikes to 39.5°C, indicating the possibility of worsening sepsis or an inadequate initial antibiotic coverage.
Laboratory reassessment shows further deterioration of renal function, with creatinine now at 3.0 mg/dL, suggesting escalating acute kidney injury. Additionally, arterial blood gases reveal a pH of 7.28, PaCO2 at 55 mmHg, and PaO2 at 58 mmHg on 60% FiO2, reflecting mixed respiratory and metabolic acidosis. In this precarious clinical setting, the team is tasked with re-evaluating the antibiotic regimen based on pending culture results, considering renal replacement therapy options, and optimizing ventilatory support to manage the intricate balance of maintaining oxygenation without further worsening barotrauma or hemodynamic compromise.
Section 4
New Diagnostic Results:
As the critical care team continues to manage the patient, new diagnostic results begin to shed light on the evolving clinical picture. Blood cultures return with a positive growth of multidrug-resistant Pseudomonas aeruginosa, prompting an immediate revision of the antibiotic regimen to include ceftazidime-avibactam and colistin, drugs known for their efficacy against this resistant organism. This change aims to target the underlying infection more effectively, as the previous antibiotic coverage was inadequate. Despite this adjustment, the patient's inflammatory markers, such as C-reactive protein and procalcitonin, remain alarmingly elevated, indicating an ongoing inflammatory response.
Simultaneously, further imaging studies, including a repeat chest X-ray and a CT scan of the thorax, reveal worsening bilateral infiltrates consistent with progressive ARDS, as well as the presence of new pleural effusions on both sides. These findings suggest an additional layer of complexity, possibly exacerbated by fluid overload and the systemic inflammatory process. The team considers the implications of these pleural effusions, debating the potential benefits and risks of performing therapeutic thoracentesis to alleviate respiratory compromise without precipitating hemodynamic instability.
In light of these results, the patient's renal function is closely monitored, with nephrology consulted to discuss the timing and modality of renal replacement therapy, given the persistent elevation in creatinine and oliguria. Continuous renal replacement therapy (CRRT) is proposed as the most viable option, allowing for gradual fluid removal and metabolic control without exacerbating the patient's already fragile hemodynamic status. This multifaceted approach underscores the necessity for advanced critical thinking and interdisciplinary collaboration to navigate the intricacies of the patient's care and facilitate any potential recovery.
Section 5
Change in Patient Status
Despite the comprehensive efforts to address the multidrug-resistant Pseudomonas aeruginosa infection and manage the progressive ARDS, the patient's condition takes a sudden turn for the worse. Over the course of the next 24 hours, the patient exhibits signs of acute hemodynamic instability, characterized by hypotension with blood pressure readings dropping to 85/55 mmHg, tachycardia with a heart rate of 125 beats per minute, and a rising lactate level of 4.5 mmol/L, indicating potential septic shock. The patient's oxygenation status deteriorates further, with arterial blood gases revealing a pH of 7.28, PaCO2 of 58 mmHg, PaO2 of 55 mmHg, and a bicarbonate level of 18 mEq/L, suggestive of worsening respiratory acidosis and hypoxemia.
Concurrently, bedside ultrasonography confirms the enlargement of pleural effusions, contributing to increased respiratory distress, and the patient experiences escalating dyspnea despite maximum ventilatory support. The critical care team initiates vasopressor therapy with norepinephrine to stabilize blood pressure and improve perfusion, while deliberating on the timing and approach for thoracentesis to address the pleural effusions. However, the potential for hemodynamic decompensation post-procedure necessitates meticulous planning and coordination with the anesthesia and surgical teams.
Nephrology is consulted again as the patient's renal function declines further, evidenced by a creatinine level of 3.2 mg/dL and continued oliguria, reinforcing the urgent need for CRRT initiation. The multidisciplinary team reassesses the patient's fluid status, balancing the delicate act of fluid removal through CRRT while ensuring adequate tissue perfusion. This critical juncture demands advanced clinical judgment and precise titration of therapeutic interventions to avert multi-organ failure and guide the patient through this precarious phase.